Fundraising Fox

Arno de Wilde

Investor

Investor at EQT Life Sciences

Amsterdam, Netherlands

Writes $11M – $65M checks · typically $25M

About

Arno de Wilde is a Managing Director at EQT Life Sciences and co-founder of its neuroscience fund, which manages €273 million in assets. He holds an MD and PhD in neurology from Amsterdam UMC, where he completed six years of clinical practice, and earned an MBA from INSEAD. De Wilde serves as a director on the boards of Aerska, Atalanta Therapeutics, and VectorY Therapeutics, and has published over 20 manuscripts and a book chapter on clinical trial design.

Experience

  1. EQT GroupManaging Directorcurrent2025 — presentАмстердам
  2. EQT GroupDirector2023 — 2024Amsterdam, North Holland, Netherlands
  3. EQT GroupVice President2022Амстердам
  4. EQT GroupAssociate2020 — 2022Амстердам
  5. EQT GroupAnalyst2019 — 2020Амстердам
  6. Amsterdam UMCMember of Societal Advisory Boardcurrent2024 — presentAmsterdam, North Holland, Netherlands
  7. AerskaBoard Directorcurrent2026 — present
  8. Atalanta TherapeuticsBoard Directorcurrent2024 — presentBoston, Massachusetts, United States
  9. VectorYBoard Directorcurrent2023 — presentAmsterdam, the Netherlands
  10. Nederlandse Vereniging van Participatiemaatschappijen (NVP)Member of VC Committeecurrent2023 — presentAmsterdam, North Holland, Netherlands
  11. Health~HollandMember of Program Committeecurrent2024 — presentThe Hague, South Holland, Netherlands
  12. Upgrade MedicalAdvisorcurrent2025 — presentUtrecht, Netherlands
  13. Bio-Neuroscience ConferenceMember of Advisory Boardcurrent2025 — present
  14. AstronauTxBoard Observer2023 — 2026London, England
  15. Asceneuron SABoard Observer2024 — 2025Lausanne, Vaud, Switzerland
  16. Nobi Smart LampsBoard Observer2022 — 2024Antwerp, Belgium
  17. QurAlisBoard Observer2022 — 2024Boston, Massachusetts, United States
  18. Amsterdam UMCPhysician-scientist (Neurology)2014 — 2020Amsterdam, North Holland, Netherlands
  19. UMC UtrechtPhysician-scientist (Neurology)2013 — 2014Utrecht, Utrecht, Netherlands
  20. UMC UtrechtGraduate Researcher (Neurology)2010 — 2013Utrecht, Netherlands

Education

  1. INSEADExecutive Master of Business Administration - M.B.A.
  2. Vrije Universiteit Amsterdam (VU Amsterdam)Doctor of Philosophy - Ph.D.
  3. Utrecht UniversityBachelor’s and Master’s in Medicine - M.D.

Skills & more

Portfolio Management4Investment Strategies1Deal Sourcing2Venture CapitalBoard of Directors

Languages Dutch · English

From Arno's professional profile.

Colleagues at EQT Life Sciences

Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Clemens van Blitterswijk
Venture Partner at EQT Life Sciences

Network8

Anne Portwich
Partner at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Clemens van Blitterswijk
Venture Partner at EQT Life Sciences
Drew Burdon
Responsible advisor at EQT Life Sciences
Fouad Azzam
Partner at EQT Life Sciences
Geraldine O'Keeffe
Partner at EQT Life Sciences

Investors connected to Arno in public investor directories — a warm-intro map.

Frequently asked questions

Where does Arno de Wilde work?
Arno de Wilde is Investor at EQT Life Sciences.
What check size does Arno de Wilde write?
Arno de Wilde typically writes checks of $11M – $65M.

Same school

Also attended INSEAD773

Patrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesStephane KurganInvestor at Index VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures

+ 767 more

Also attended Vrije Universiteit Amsterdam (VU Amsterdam)145

Brendan Bulik-SullivanInvestor at GV (Google Ventures)Kyang YungInvestor at DaphniJohann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at NoaberIrene KrijgsmanProgramma manager at Noaber

+ 139 more

Also attended Utrecht University85

Matthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at NoaberIrene KrijgsmanProgramma manager at NoaberMarlene van LooProgramma manager at NoaberRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalDr. Benedikt BuchspiesPrincipal - Technology Research and Science at Planet A Ventures

+ 79 more

Shared employers

Also worked at Aerska2

David HardwickeInvestment Consultant at Pathway BioventuresJack O'MearaAngel

Also worked at Nederlandse Vereniging van Participatiemaatschappijen (NVP)7

René SavelsbergCo-Founder & Partner at SET VenturesRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesDylan PeralesPrincipal at PureTerra VenturesEwout PrinsManaging Partner at Holland CapitalMichael LucassenManaging Partner at TIIN CapitalBjörn AartsESG Director at Rabo Corporate Venturing

+ 1 more

Also worked at Health~Holland2

René KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesThom FrielinkAssociate at Curie Capital

Also worked at Asceneuron SA5

Henrijette RichterManaging Partner at Sofinnova PartnersHakan GokerManaging Director at M VenturesDeborah HarlandChair, LifeArc Ventures Investment Committee at LifeArc VenturesDr. Jeanne BolgerAdvisor at Apollo Health VenturesJasper BosGeneral Partner at Forbion